Key Takeaways
- • Catalyst Healthcare Real Estate and Nuveen Real Estate formed a $400 million equity joint venture to support approximately $1.3 billion in total development costs across Catalyst's national pipeline, according to a PR Newswire release.
- • The venture will fund a majority of Catalyst's contractual ground-up development initiatives from 2026 through 2028, with an emphasis on high-growth U.S. markets.
- • Nuveen, which reported $136 billion in assets under management as of June 30, 2026, brings scale and healthcare development capital to Catalyst's medical office and specialty healthcare pipeline.
- • The Blackbirch Capital / CBRE Healthcare team served as exclusive advisor to Catalyst on the venture's formation.
Summary
Catalyst Healthcare Real Estate, a national healthspan-focused development and investment firm, and Nuveen Real Estate, one of the largest real estate investment managers globally, have announced the formation of a $400 million equity joint venture. The vehicle will support approximately $1.3 billion in total development costs across Catalyst's national pipeline, according to the announcement distributed by PR Newswire.
The joint venture will fund a majority of Catalyst's contractual ground-up development initiatives scheduled between 2026 and 2028, with a focus on high-growth markets throughout the United States. Catalyst describes the platform as spanning medical office and specialty healthcare facilities as well as healthspan initiatives supporting academic institutions and healthcare systems. Founder and CEO Chad Henderson said the partnership strengthens the company's ability to deliver healthcare real estate across a broad range of asset types and markets. Chief Development Officer Eric Fischer cited Nuveen's geographic reach, sector depth and long-term capital discipline as supporting the pipeline's expansion.
Andrew Pyke, Nuveen's Head of Healthcare Real Estate, said Catalyst has a proprietary pipeline of development opportunities generated through its industry relationships. Tim Racine, Nuveen's Head of Healthcare Development, described Catalyst's approach as innovative. Nuveen, which manages $136 billion in assets as of June 30, 2026 across public and private real estate debt and equity, has raised significant healthcare development equity since 2025 and is focused on high-acuity, best-in-class facilities nationwide.
The Blackbirch Capital / CBRE Healthcare team acted as exclusive advisor to Catalyst on the transaction. The announcement did not disclose the specific allocation split between the partners or the project-level terms of the venture.
The joint venture will fund a majority of Catalyst's contractual ground-up development initiatives scheduled between 2026 and 2028, with a focus on high-growth markets throughout the United States. Catalyst describes the platform as spanning medical office and specialty healthcare facilities as well as healthspan initiatives supporting academic institutions and healthcare systems. Founder and CEO Chad Henderson said the partnership strengthens the company's ability to deliver healthcare real estate across a broad range of asset types and markets. Chief Development Officer Eric Fischer cited Nuveen's geographic reach, sector depth and long-term capital discipline as supporting the pipeline's expansion.
Andrew Pyke, Nuveen's Head of Healthcare Real Estate, said Catalyst has a proprietary pipeline of development opportunities generated through its industry relationships. Tim Racine, Nuveen's Head of Healthcare Development, described Catalyst's approach as innovative. Nuveen, which manages $136 billion in assets as of June 30, 2026 across public and private real estate debt and equity, has raised significant healthcare development equity since 2025 and is focused on high-acuity, best-in-class facilities nationwide.
The Blackbirch Capital / CBRE Healthcare team acted as exclusive advisor to Catalyst on the transaction. The announcement did not disclose the specific allocation split between the partners or the project-level terms of the venture.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.